Neuralink said on Twitter yesterday:
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.
Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!”
FDA media relations could not be immediately reached for comment.
Citing anonymous current and former employees, Reuters has reported that the FDA previously rejec…